Frontlight ResearchEarly access
Heart failure trials in South Korea
40 of 57 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffects of Primary Physician Presence in AI-Synthesized SGLT2 Inhibitor Educational Videos for Heart Failure
- Where
- Daegu
- Age
- 19 years and over
- People
- 150
- Run by
- Keimyung University Dongsan Medical Center
See details and how to joinNCT07937540 - Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Pusan, Seoul
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Deagu, Gwangju, Incheon, Seongnam, Seoul, Wonju-si, Gangwon State, Yangsan
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Busan, Gwangju, Incheon, Seongnam, Seoul, Wŏnju
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Daejeon, Gwangju, Seongnam-si, Gyeonggi-do, Seoul, Wonju-si, Gangwon-do
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Seoul, Yangsan
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - No phaseTaking peopleRoutine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
- Where
- Changwon, Incheon, Seoul
- Age
- 19 years and over
- People
- 500
- Run by
- Samsung Medical Center
See details and how to joinNCT07482865 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wŏnju, Yangsan
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Busan, Seongnam-si, Seoul
- Age
- 18 years and over
- People
- 1,280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Jongno, Seodaemun, Seoul, Yangsan
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Anyang-si, Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gwangju, Gwangmyeong, Incheon, Junggu, Seongnam-si, Seoul, Uijeongbu-si, Wŏnju, Yangsan
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - Phase 1Taking peopleA Phase I Study of Allogeneic Myocardium-Derived Mesenchymal Stem Cells (HB1011) in Patients With Ischemic Cardiomyopathy
- Where
- Seongnam-si
- Age
- 19 years to 85 years
- People
- 12
- Run by
- HieraBio Inc.
See details and how to joinNCT07861035 - Phase 2Taking peopleA Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Cheongju-si, Daegu, Gangwon-do, Seongnam-si, Gyeonggi-do, Seoul
- Age
- 40 years to 84 years
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979362 · EU 2024-515796-35-00 - Phase 3Not yet taking people in South KoreaA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongbuk-Gu, Seoul, Suwon, Uijeongbu-si, Yangsan
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Bucheon-si, Busan, Cheongju-si, Daegu, Daejeon, Gangneung, Gwangju, Incheon, Seoul, Wŏnju
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197 - Phase 4Taking peopleDelayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
- Where
- Daegu, Seongnam-si, Seoul, Suwon
- Age
- 18 years and over
- People
- 80
- Run by
- Kyungsub Song
See details and how to joinNCT07572032 - Phase 4Taking peopleSTEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
- Where
- Daegu, Seongnam-si, Seoul, Suwon, Yangsan
- Age
- 19 years and over
- People
- 80
- Run by
- Kyungsub Song
See details and how to joinNCT07631156 - Phase 4Taking peopleClinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
- Where
- Seoul
- Age
- 19 years and over
- People
- 200
- Run by
- Samsung Medical Center
See details and how to joinNCT07776054 - Phase 3Taking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Anyang-si, Daegu, Daejeon, Gwangju, Incheon, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Wŏnju, Yangsan
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseTaking peopleEarly Detection and IntervenTion in Heart Failure
- Where
- Seoul
- Age
- 65 years and over
- People
- 18,000 worldwide
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07731490 - No phaseTaking peopleContrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure
- Where
- Seongnam-si
- Age
- 20 years and over
- People
- 190
- Run by
- Jin Joo Park
See details and how to joinNCT07550790 - Phase 4Taking peopleENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
- Where
- Bucheon-si, Changwon, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon, Pusan, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Ulsan
- Age
- 19 years and over
- People
- 1,040
- Run by
- Duk-Woo Park, MD
See details and how to joinNCT05672836 - Phase 4Not yet taking people in South KoreaEfficacy of Verciguat in TR and RV Failure
- Where
- Daejeon
- Age
- 19 years and over
- People
- 100
- Run by
- Daejeon St. Mary's hospital
See details and how to joinNCT07668739 - No phaseNot yet taking people in South KoreaIn-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)
- Where
- Yongin
- Age
- 20 years and over
- People
- 1,500
- Run by
- Yonsei University
See details and how to joinNCT07622485 - Phase 4Taking peopleEffect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation
- Where
- Seoul
- Age
- 19 years to 84 years
- People
- 390
- Run by
- Yonsei University
See details and how to joinNCT06528262